51 results about "Asthma attack" patented technology

A method is provided for predicting an onset of an asthma attack. The method includes sensing at least one parameter of a subject without contacting or viewing the subject or clothes the subject is wearing, and predicting the onset of the asthma attack at least in part responsively to the sensed parameter. Also provided is a method for predicting an onset of an episode associated with congestive heart failure (CHF), including sensing at least one parameter of a subject without contacting or viewing the subject or clothes the subject is wearing, and predicting the onset of the episode at least in part responsively to the sensed parameter. Other embodiments are also described.

A method is provided for predicting an onset of an asthma attack. The method includes sensing at least one parameter of a subject without contacting or viewing the subject or clothes the subject is wearing, and predicting the onset of the asthma attack at least in part responsively to the sensed parameter. Also provided is a method for predicting an onset of an episode associated with congestive heart failure (CHF), including sensing at least one parameter of a subject without contacting or viewing the subject or clothes the subject is wearing, and predicting the onset of the episode at least in part responsively to the sensed parameter. Other embodiments are also described.

Enables recognition of events within motion data including but not limited to motion capture data obtained from portable wireless motion capture elements such as visual markers and sensors, radio frequency identification tags and motion sensors within mobile device computer systems, or calculated based on analyzed movement associated with the same user, other user, historical user or group of users. Provides low power transmission of events. Greatly reduces storage for events such as a shot, move or swing of a player, a concussion of a player, boxer, rider or driver, or a heat stroke, hypothermia, seizure, asthma attack, epileptic attack. Events may be correlated with image(s) as captured from internal/external camera(s) or nanny cam, for example to enable saving video of the event, such as the first steps of a child, violent shaking events, sporting, military or other motion events including concussions, or falling events associated with an elderly person.

Transcutaneous electrical and magnetic nerve stimulation devices are disclosed, along with methods of averting imminent medical attacks using energy that is delivered noninvasively by the devices. The attacks comprise asthma attack, epileptic seizure, attacks of migraine headache, transient ischemic attack or stroke, onset of atrial fibrillation, myocardial infarction, onset of ventricular fibrillation or tachycardia, panic attack, and attacks of acute depression. The imminence of an attack is forecasted using grey-box or black-box models as used in control theory. In preferred embodiments of the disclosed methods, a vagus nerve in the neck of a patient is stimulated noninvasively to avert the attack.

A method for treating the lung during an acute episode of reversible chronic obstructive pulmonary disease such as an asthma attack. The method comprises transferring energy to an airway wall of an airway such that a diameter of the airway is increased. The energy may be transferred to the airway wall prior to, during or after an asthma attack. The energy may be transferred in an amount sufficient to temporarily or permanently increase the diameter of the airway. The method may be performed while the airway is open, closed or partially closed.

A method is provided for predicting an onset of an asthma attack. The method includes sensing at least one parameter of a subject without contacting or viewing the subject or clothes the subject is wearing, and predicting the onset of the asthma attack at least in part responsively to the sensed parameter. Also provided is a method for predicting an onset of an episode associated with congestive heart failure (CHF), including sensing at least one parameter of a subject without contacting or viewing the subject or clothes the subject is wearing, and predicting the onset of the episode at least in part responsively to the sensed parameter. Other embodiments are also described.

The invention provides a traditional Chinese medicine reagent for warming lung, eliminating cold, resolving sputum and relieving asthma, comprising blackberry lily, ephedra, dried ginger, asarum, prepared pinellia, michaelmas daisy, schisandra chinensis, coltsfoot flowers, licorice and jujube. The traditional Chinese medicine reagent for warming lung, eliminating cold, resolving sputum and relieving asthma is characterized by being prepared from the following steps of preparing the raw materials according to a ratio, putting into a vessel, soaking with 600-1000ml warm water, then boiling with big fire, changing the big fire into small fire, decocting for 30-45m, removing the vessel from a fire source, closing the fire source, cooling physic liquor in the vessel until the temperature is 25-40 DEG C, filtering the physic liquor with a filter screen, and filtering off dregs. The prepared traditional Chinese medicine reagent is suitable for treating cold asthma attack stage. The invention has the advantages of treating the root cause from symptoms, being warm without hot, relieving dryness, having peace property, being good at discharging lung qi, eliminating phlegm, stopping cough and specially discharging lung.

The invention features methods and apparatus for the treatment of asthma patients. A controlled supply of breathable air delivered to a patient interface or mask (4) is controlled for patient comfort to maintain a steady pressure level in a range 2 to 4 cm H₂O to accommodate patient respiration. The breathable air is cleaned by a high efficiency particulate arresting filter (10) to remove allergens from the air supply. The apparatus may be programmed to automatically detect asthma-related symptoms such as an asthma attack by analyzing the respiratory flow of the patient. In response to the detection of such an attack, the apparatus may provide an audible warning or if configured with a treatment delivery module (14A, 14B), the device may administer a therapeutically effective dose of a drug or substance, for example, a broncho-dilator, to alleviate the patient's breathing difficulty. Preferred mask designs allow for proper CO₂ washout to accommodate the low pressures supplied to the mask and prevent asphyxia.

Asthma is an inflammatory disease of the airways in the lungs and bronchial tubes, the lower airway, that impairs breathing, causes wheezing, coughing and excess mucus and phlegm production. Asthma is the source of about one-fourth of all emergency room admissions. Throat lozenges and orally-retained liquids, such as syrups, containing magnesium are used in the invention to rapidly terminate asthma attacks and prevent asthma attacks. Magnesium lozenges and magnesium orally-retained liquids are effective in asthma rescue. Treatment of asthma with orally-retained magnesium, an essential human nutrient, is much safer than treatment by drugs yet they appear as effective as current drugs. An added benefit from magnesium treatment is relaxation. A preferred composition is 100 mg of magnesium from 400 mg magnesium chloride in a 4-gram lozenge. Magnesium lozenges or orally-retained liquids are administered as needed to treat asthma attacks or prevent incipient asthma attacks. Throat lozenges and orally-retained liquids of any pharmaceutically acceptable composition containing any pharmaceutically acceptable compound of magnesium are disclosed and claimed as effective in the treatment and prevention of asthma.

The invention relates to a traditional Chinese medicinal composition for treating asthma. The traditional Chinese medicinal composition is prepared through using 1.8-2.2 parts by weight of Euphorbia kansui, 0.8-1.2 parts by weight of Semen Brassicae and 0.8-1.2 parts by weight of Manchurian wildginger. The invention also provides an application of the traditional Chinese medicinal composition for treating asthma. The traditional Chinese medicinal composition has the following advantages: the compatibility accords with monarch, minister, assistant and guide principles of the traditional Chinese medicinal science, and pharmacodynamic experiments verify that the traditional Chinese medicinal composition can substantially reduce the child asthma attacking frequency, mitigate the disease degree and improve the clinic curative effect; the traditional Chinese medicinal composition has substantial clinic curative effects on COPD in the stable stage, and can mitigate symptoms, reduce the acute attack frequency and improve the lung functions; and the traditional Chinese medicinal composition has less traditional Chinese medicines, good curative effects and a low cost, and can be clinically used for a long term.

The purpose of the invention is to provide a Chinese patent medicine of a lung-warming panting-calming granule for treating cold wheezing during bronchial asthma attack phases. Aiming at the problems of single dosage form and insufficient drug effect research for current applications of traditional Chinese medicines in asthma treatment, the lung-warming panting-calming granule is prepared based on a hospital preparation used in our hospital for years, and the effectiveness and safety of the granule are verified through pharmacological research and clinical research.

The invention relates to a Chinese medicinal preparation for preventing and curing bronchial asthma. The preparation is prepared from radix astragalus, Chinese angelica, glossy privet fruit, epimedium herb, mahonia leaf and other Chinese medicine herbs; animal tests prove that the preparation can reduce the number of acidophil in a bronchoalveolar lavage fluid and blood, improves the pathological changes of inflammation of lung and bronchia and the like. The method uses the strengthening of body resistance and the curing of root causes as principles, starts from the regulation of qi and blood and yin and yang, effectively increases the immunologic function of patients, improves the degree of asthma attack and gradually relieves and even prevents the recurrent attacks of asthma. The Chinese medicinal preparation for preventing and curing bronchial asthma provides an effective Chinese medicinal preparation for preventing and curing asthma for the patients with asthma and has good application prospect.

The invention relates to traditional Chinese medicine composition for treating pediatric asthma in paracmasia. The traditional Chinese medicine composition is prepared by the following APIs(Active Pharmaceutical Ingredients) in parts by weight: 4-8 parts of semen brassicae, 4-8 parts of rhizoma corydalis, 2-4 parts of angelica dahurica, 2-4 parts of euphorbia kansui, 2-4 parts of asarum sieboldii, 2-20 parts of fresh ginger, 2-20 parts of syzygium aromaticum and 2-20 parts of cinnamomum cassia. The invention also relates to the application of the traditional Chinese medicine composition for treating the pediatric asthma in paracmasia. The traditional Chinese medicine composition disclosed by the invention has the advantages that 1, the preparation technology is simple, the total effective rate is high, and the use is convenient; 2, the blood serum EOS level can be reduced, the chronic inflammation in bronchus can be relived, and the occurrence and the development of asthma can be effectively reduced; 3, the lung function index of a children patient can be improved, resistance in an airway of the children patient can be reduced, and the asthma attacking degree can be reduced; 4, the syndrome integral of the children patient can be reduced, the asthma attacking frequency can be reduced, the living quality of the children patient can be obviously improved, and certain function for regulating biased constitution of the children patient can be obtained; 5, no wound can be generated, no toxic and side effects are generated, the asthma attacking can be delayed, the attacking degree can be relieved, and the living quality of the patient can be increased.

According to the invention there is provided pemirolast, or a pharmaceutically acceptable salt thereof, for use in the therapeutic treatment of asthma, such as an acute asthma attack. Suitable lower doses of pemirolast are least about 110 mg per day.

The purpose of the invention is to provide a Chinese patent medicine of a root-securing and panting-calming granule for treating deficiency-type wheezing during bronchial asthma attack phases. Aiming at the problems of single dosage form and insufficient drug effect research for current applications of traditional Chinese medicines in asthma treatment, the root-securing and panting-calming granule is prepared based on a hospital preparation used in our hospital for years, and the effectiveness and safety of the granule are verified through pharmacological research and clinical research.

The invention discloses a medicine for treating asthma and kidney qi deficiency, an animal model and an establishing and using method. The medicine for treating asthma and kidney qi deficiency is prepared from 12g of prepared rehmannia roots, 12g of pulp of dogwood fruit, 12g of rhizoma dioscoreae, 12g of rhizoma alismatis, 12g of radix sophorae flavescentis, 12g of Japanese metaplexis pericarp, 12g of tree peony bark, 12g of poria cocos, 5g of schisandra chinensis, 8g of agilawood pieces, 15g of inula flowers, 15g of indigo naturalis and clam powder and 15g of raw radix astragalis. In the early period, a kidney qi deficiency and asthma symptom combined rat model is established, and it is observed that kidney tonifying and asthma relieving soup and glucocorticoid can correct Th1/Th2 unbalance by adjusting expression of transcription factors. Specificity transcription factors, key cell factors and tiny RNA of a T cell subset serve as indexes, an internal mechanism of kidney qi deficiency asthma attacking and Treg/Th balance is proved, and a multi-target-point multi-layered network type regulatory mechanism possibly existing in traditional Chinese medicine for treating asthma is disclosed.